Taiwan COVID vaccine maker says it had wanted to do stage 3 trials
06/03/2021 11:13 PM
CNA file photo
Taipei, June 3 (CNA) United Biomedical, a Taiwan biopharmaceutical firm developing COVID-19 vaccines, on Thursday said it had initially planned on following international norm and entering phase 3 clinical trials before seeking government approval for its COVID-19 vaccine.
In response to public concerns that United Biomedical's vaccines could be launched without going through phase-three clinical trials, the company's Chief Operating Officer (COO) Peng Wen-jiun (彭文君) said at a forum that the company had initially planned on following through the international norm, but Taiwan's Center for Drug Evaluation (CDE) and Food and Drug Administration (FDA) suggested that the company increase the number of participants to a larger-than-normal scale in the second phase of clinical trials instead.